Host Interactions with Engineered T-cell Micropharmacies

Overview of attention for article published in Cancer Immunology Research, June 2023

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
One of the highest-scoring outputs from this source (#4 of 1,603)
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (93rd percentile)

So far, Altmetric has seen 50 news stories from 50 outlets.

DURHAM, N.C., July 26, 2023. CoImmune, Inc., a clinical stage immuno-oncology company working to redefine cancer treatment…

- SEAKER cells localize specifically to tumors and convert bioactive prodrugs into therapeutic anticancer drugs in mouse models …

- SEAKER cells localize specifically to tumors and convert bioactive prodrugs into therapeutic anticancer drugs in mouse models …

- SEAKER cells localize specifically to tumors and convert bioactive prodrugs into therapeutic anticancer drugs in mouse models …

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity, including 46 additional news stories.